Chronic Lymphocytic Leukemia/Small Lymphocytic Lymphoma

Chronic Lymphocytic Leukemia/Small Lymphocytic Lymphoma — Trials · CancerIndex

Clinical trials

Registered studies

1,406 studies whose conditions map to this entity or one of its descendants. Status and phase are as posted on ClinicalTrials.gov. 50 studies per page.

Active: 298
Recruiting: 144
Ph III recruiting: 19
Growth YoY: −14%
Industry share: 35%
Top sponsor: City of Hope Medical Center
Termination share: 34.8%

Computedformula ci-trial-intel-v1 · interventional studies · entity + NCIt descendants · hover a figure for its formulaCompare cancers Terminated studies (273)

clinicaltrialsPublishedShowing 301–302 of 302 studies matching the filters · status and phase as posted by the registrant; each row links to the study record.

NCT	Title	Status	Phase	Enrollment (n)	Sponsor	Countries	Last update	Source
NCT00090090	Elsamitrucin (SPI 28090) for Relapsed or Refractory Non-Hodgkin's Lymphoma	completed	Phase 2	114	Spectrum Pharmaceuticals, IncINDUSTRY	1	Jan 15, 2008	clinicaltrials
NCT00058656	Autologous T Cell Immunotherapy for Chronic Lymphocytic Leukemia (CLL) Patients	completed	Phase 1 / Phase 2	18	Xcyte TherapiesINDUSTRY	1	Nov 22, 2006	clinicaltrials